Department of Gastroenterology, Nizam's Institute of Medical Sciences, Hyderabad, India.
Arq Gastroenterol. 2024 Mar 4;61:e23112. doi: 10.1590/S0004-2803.24612023-112. eCollection 2024.
Common bile duct (CBD) stones are known to complicate 10-15% of gallstone diseases. Endoscopic retrograde cholangiopancreatography (ERCP) is the therapeutic modality of choice for bile duct clearance in CBD stones but may fail to achieve stone clearance. This prospective study was done to identify the predictors of failure of CBD clearance with ERCP.
This prospective study was done to identify the predictors of failure of CBD clearance with ERCP.
All consecutive patients with bile duct stones undergoing ERCP at a tertiary care center were prospectively included from October 2020 to October 2021. The study's primary outcome was to identify and analyze factors that could predict the failure of complete CBD clearance.
A total of 120 patients (50.8% males, median age: 53.5 years) were included in the final analysis. Successful clearance of CBD stones during the index procedure was achieved in 70% of patients. At a cut-off stone diameter of >10.5 mm and CBD diameter of >12.5 mm, the AUC was 0.890 and 0.884, respectively, to predict failed clearance of CBD. On multivariate analysis, stone diameter ≥15 mm [odds ratio (OR) 16.97, 95% confidence interval (CI): 1.629-176.785], location of stones in hepatic ducts (OR 7.74, 95%CI: 2.041-29.332), presence of stricture distal to stone (OR 6.99, 95%CI: 1.402-34.726) and impacted stone (OR 21.61, 95%CI: 1.84-253.058) were independent predictors of failed bile duct clearance.
Stone size and location are independent predictors of failed bile duct clearance. The endoscopist should consider these factors while subjecting a patient to biliary ductal clearance to plan additional intervention.
• Failure to clear bile duct stones in the index ERCP can be seen in 15-20% of cases, and identifying the factors associated with failure is important.
• A prospective analysis was conducted to identify and analyze the factors that could predict the failure of complete CBD clearance.
• The present study reported a successful clearance of CBD stones during the index procedure in only 70% of patients.
• A stone diameter ≥15 mm, location of stones in hepatic ducts, presence of stricture distal to stone, and impacted stone were independent predictors of failed bile duct clearance.
胆总管(CBD)结石在 10-15%的胆石病中较为常见。内镜逆行胰胆管造影术(ERCP)是清除 CBD 结石的首选治疗方法,但可能无法清除所有结石。本前瞻性研究旨在确定 ERCP 治疗 CBD 结石清除失败的预测因素。
本前瞻性研究旨在确定 ERCP 治疗 CBD 结石清除失败的预测因素。
本研究纳入了 2020 年 10 月至 2021 年 10 月在一家三级医疗中心接受 ERCP 治疗的连续胆汁淤积患者。主要研究终点是确定并分析可能预测 CBD 完全清除失败的因素。
共纳入 120 例患者(50.8%为男性,中位年龄:53.5 岁)进行最终分析。70%的患者在指数操作中成功清除 CBD 结石。当结石直径>10.5mm 和 CBD 直径>12.5mm 时,预测 CBD 清除失败的 AUC 分别为 0.890 和 0.884。多变量分析显示,结石直径≥15mm [比值比(OR)16.97,95%置信区间(CI):1.629-176.785]、肝内胆管结石位置(OR 7.74,95%CI:2.041-29.332)、结石远端狭窄(OR 6.99,95%CI:1.402-34.726)和嵌顿结石(OR 21.61,95%CI:1.84-253.058)是 CBD 清除失败的独立预测因素。
结石大小和位置是 CBD 清除失败的独立预测因素。内镜医生在对患者进行胆管清除时应考虑这些因素,以计划额外的干预措施。